CUSIP: N69605108
Q1 2023 13F Holders as of 31 Mar 2023
-
Type / Class
-
Equity / Ordinary Shares, Euro 0.12 par value per share
-
Shares outstanding
-
65,632,680
-
Total 13F shares
-
21,781,494
-
Share change
-
+479,639
-
Total reported value
-
$173,888,454
-
Price per share
-
$8.06
-
Number of holders
-
21
-
Value change
-
+$3,756,313
-
Number of buys
-
5
-
Number of sells
-
9
Quarterly Holders Quick Answers
What is CUSIP N69605108?
CUSIP N69605108 identifies PHVS - Pharvaris N.V. - Ordinary Shares, Euro 0.12 par value per share in SEC institutional holdings data.
Need full ownership history?
Open the full security ownership history page.
Explore More Reporting Periods
Jump to adjacent filing periods for faster comparison and easier crawl discovery.
-
Newer quarter:
Q2 2023
-
Previous quarter:
Q4 2022
Recent filing periods for CUSIP N69605108:
Institutional Holders of Pharvaris N.V. - Ordinary Shares, Euro 0.12 par value per share (PHVS) as of Q1 2023
As of 31 Mar 2023,
Pharvaris N.V. - Ordinary Shares, Euro 0.12 par value per share (PHVS) was held by
21 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
21,781,494 shares.
The largest 10 holders included
FMR LLC, Foresite Capital Management IV, LLC, VIKING GLOBAL INVESTORS LP, Bain Capital Life Sciences Investors, LLC, GENERAL ATLANTIC, L.P., venBio Partners LLC, Novo Holdings A/S, Cormorant Asset Management, LP, 5AM Venture Management, LLC, and SILVERARC CAPITAL MANAGEMENT, LLC.
This page lists
21
institutional shareholders reporting positions in this security
for the Q1 2023 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.